BIOTIE THERAPIES

biotie-therapies-logo

Biotie is a specialized drug development company focused on central nervous system and inflammatory diseases. It has several innovative small molecule and biological drug candidates at different stages of clinical development. Biotie's products address diseases with high unmet medical need and significant market potential, including addiction and a broad range of inflammatory conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S.

#SimilarOrganizations #People #Financial #Website #More

BIOTIE THERAPIES

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1998-01-01

Address:
Finans, Nigde, Turkey

Country:
Turkey

Website Url:
http://www.biotie.com

Total Employee:
11+

Status:
Active

Contact:
+135822748900

Email Addresses:
[email protected]

Total Funding:
252.46 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Virginia Region GeoTrust SSL Symantec.cloud Microsoft SharePoint Server 2010


Similar Organizations

3biotech-logo

3Biotech

3Biotech is a medical and biological development company, focusing directly on the needs of clients.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aprea-logo

Aprea

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

fermcom-bio-vnt-logo

FermCom Bio-VNT

FermCom Bio-VNT is a research and development company focused on biotechnology and network applications.

onco-nx-logo

Onco-NX

Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

respivert-logo

RespiVert

Respivert is a small molecule drug discovery company for the treatment of chronic obstructive pulmonary diseases.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

syntopix-group-logo

Syntopix Group

Syntopix Group is a drug development company focused on prescription and over-the counter products for the treatment of common inflammatory.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

tpp-global-development-logo

TPP Global Development

TPP Global Development is a preclinical stage drug development company focused on nervous system disorders, immunology, and oncology.


Current Advisors List

ismail-kola_image

Ismail Kola Board Member @ Biotie Therapies
Board_member

bradley-bolzon_image

Bradley Bolzon Chairman @ Biotie Therapies
Board_member
2011-01-01

peter-fellner_image

Peter Fellner Chairman @ Biotie Therapies
Board_member

william-burns_image

William Burns Deputy Chairman @ Biotie Therapies
Board_member
2012-03-29

Current Employees Featured

william-burns_image

William Burns
William Burns Director @ Biotie Therapies
Director
2011-02-07

not_available_image

Anna-Maija Järvenpää
Anna-Maija Järvenpää Clinical Project Manager @ Biotie Therapies
Clinical Project Manager
2008-08-01

not_available_image

David Smith
David Smith Vice-President of Inflammatory Disease Area @ Biotie Therapies
Vice-President of Inflammatory Disease Area
2009-03-01

not_available_image

Kathleen Martin
Kathleen Martin Vice-President of Project and Portfolio Management @ Biotie Therapies
Vice-President of Project and Portfolio Management
2007-04-01

not_available_image

Steve Bandak
Steve Bandak CMO @ Biotie Therapies
CMO
2007-01-01

not_available_image

Kai Lähdesmäki
Kai Lähdesmäki CBO @ Biotie Therapies
CBO
1999-04-01

Founder


markku-jalkanen_image

Markku Jalkanen

Stock Details


Company's stock symbol is NASDAQ:BITI

Acquisitions List

Date Company Article Price
2011-01-11 Synosia Therapeutics Synosia Therapeutics acquired by Biotie Therapies N/A

Official Site Inspections

http://www.biotie.com Semrush global rank: 5.64 M Semrush visits lastest month: 564

  • Host name: ec2-3-82-161-243.compute-1.amazonaws.com
  • IP address: 3.82.161.243
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Biotie Therapies" on Search Engine